Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.dipnapharmachem.com | |
Market Cap | 21.37 Cr. | |
Enterprise Value(EV) | 31.35 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.97 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 18.31 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 41.25 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 24.86 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 0.72 | Calculated using Price: 17.85 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.20 Cr. | 11,970,000 Shares |
FaceValue | 10 | |
Company Profile | ||
No Company Profile found. |
1 Day |
|
-1.65% |
1 Week |
|
-10.97% |
1 Month |
|
-11.19% |
3 Month |
|
-13.14% |
6 Month |
|
|
1 Year |
|
|
2 Year |
|
|
5 Year |
|
|
10 Year |
|
5 years | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 13.24 | 6.78 | 11.39 | 4.32 | 101.02 | |
Return on Capital Employed (%) | 7.16 | 7.98 | 5.42 | 3.54 | 18.06 | |
Return on Assets (%) | 0.55 | 0.25 | 0.36 | 0.11 | 3.82 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 0 | 0 | 1 | 1 | 2 | |
Non Curr. Liab. | 3 | 4 | 3 | |||
Curr. Liab. | 11 | 14 | 15 | 21 | 31 | |
Minority Int. | ||||||
Equity & Liab. | 11 | 14 | 18 | 25 | 36 | |
Non Curr. Assets | 0 | 0 | 0 | 0 | 0 | |
Curr. Assets | 11 | 14 | 18 | 25 | 36 | |
Misc. Exp. not W/O | ||||||
Total Assets | 11 | 14 | 18 | 25 | 36 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Net Sales | 17 | 20 | 31 | 31 | 73 | |
Other Income | 0 | 0 | 0 | 0 | 0 | |
Total Income | 17 | 20 | 31 | 31 | 73 | |
Total Expenditure | -16 | -20 | -30 | -31 | -71 | |
PBIDT | 0 | 0 | 0 | 0 | 2 | |
Interest | 0 | 0 | 0 | 0 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | ||
Taxation | 0 | 0 | 0 | 0 | ||
Exceptional Items | ||||||
PAT | 0 | 0 | 0 | 0 | 1 | |
Adjusted EPS | 4 | 2 | 4 | 1 | 69 |
Particulars | 5 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -3 | -2 | 3 | |||
Cash Fr. Inv. | 0 | |||||
Cash Fr. Finan. | 3 | 3 | -3 | |||
Net Change | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 |
Sat, 04 Feb 2023
Outcome Of Extra Ordinary General Meeting Held On 4Th February 2023 In Terms Of The Regulation 30 Of The SEBI (LODR) Regulations 2015. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the members of the Company at their Extra Ordinary General Meeting of the Company held today i.e. on 4th February 2023 through Video Conferencing (VC) / Other Audio Video Means (OAVM) which was commenced on 4:07 P.M. and concluded on 4:14 P.M. have discussed and considered the businesses mentioned in the notice of Extra Ordinary General Meeting. |
Sat, 04 Feb 2023
Outcome Of Extra Ordinary General Meeting Held On 4Th February 2023 In Terms Of The Regulation 30 Of The SEBI (LODR) Regulations 2015 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the members of the Company at their ExtraOrdinary General Meeting of the Company held today i.e. on 4th February 2023 through Video Conferencing (VC) / Other Audio Video Means (OAVM) which was commenced on 4:07 P.M. and concluded on 4:14 P.M. have discussed and considered the businesses mentioned in the notice of Extra Ordinary General Meeting |
Tue, 31 Jan 2023
Announcement under Regulation 30 (LODR)-Resignation of Director Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with Para a of Part A of Schedule III to the said Regulations we hereby inform you that Ms. Chinu Kalal has resigned from the post of the Independent Director w.e.f. 31st January 2023. |
Fri, 03 Feb 2023 |
|
|
|
|
|